Catheter-related bloodstream infection differential diagnosis

Jump to navigation Jump to search


Jason Le, B.S.[1]

Catheter-related bloodstream infection (CRBSI) requires both documented bacteremia or fungemia and evidence that the catheter is the source. There is no single microbiologic gold standard; the differential therefore addresses both whether a true bloodstream infection is present and whether the catheter, rather than another focus, is responsible.[1]

The major diagnostic alternatives are catheter colonization or localized catheter infection, blood-culture contamination, secondary bloodstream infection from another focus, mucosal barrier injury/translocation-associated bacteremia, endovascular or metastatic infection with secondary catheter seeding, and noninfectious fever.

Differential diagnosis

Differential diagnosis Distinguishing features Diagnostic tests / key differentiators
Catheter colonization Microorganisms recovered from the catheter tip, segment, or hub without compatible bloodstream infection; peripheral blood cultures are negative. Catheter-tip or hub culture alone does not establish CRBSI. When the catheter is removed, semiquantitative or quantitative catheter cultures may document colonization, but systemic BSI requires compatible blood-culture evidence. A catheter-tip or segment culture ≥15 CFU (semiquantitative) or ≥103 CFU/mL (quantitative) with negative blood cultures denotes colonization only.[1][2]
Exit-site infection Erythema, induration, or purulence confined to the area within approximately 2 cm of the catheter exit site, without concurrent BSI. Local examination identifies the localized process. Absence of bacteremia distinguishes it from CRBSI.[1]
Tunnel infection Tenderness, erythema, or induration extending >2 cm from the exit site along the subcutaneous catheter tract, with or without concomitant bacteremia. Examine the entire subcutaneous catheter tract. This is a localized catheter infection and may coexist with bloodstream infection.[3]
Port-pocket infection Infection, infected fluid, or abscess involving the subcutaneous reservoir pocket of an implanted port. Examine the pocket for local inflammatory findings; bloodstream infection may coexist but is not required for the localized diagnosis.[4]
Blood-culture contamination A blood culture grows a common commensal without sufficient corroboration for true bacteremia. A single blood culture positive for a common commensal is classified as a contaminant in surveillance definitions, whereas recognized pathogens require only one positive culture. For common commensals, NHSN criteria require the same organism from at least 2 separate blood draws; clinical interpretation should still incorporate the organism, number and timing of positive cultures, and collection method. Catheter-drawn cultures have greater contamination concerns than peripheral venipuncture.[5][6]
Secondary bloodstream infection Bacteremia is present, but another primary infectious focus is more likely than the catheter, such as pneumonia, intra-abdominal infection, urinary infection, surgical-site infection, or skin/soft-tissue infection. Actively search for non-catheter sources before attributing the BSI to the catheter. Catheter attribution is supported by concordant microbiology and, when applicable, differential time to positivity (DTP), quantitative culture results, or concordant catheter-tip culture.[1][7]
Mucosal barrier injury / translocation-associated bacteremia Particularly relevant in neutropenic, mucositis, or allogeneic hematopoietic stem-cell-transplant patients. Eligible enteric organisms or viridans streptococci may cause bloodstream infection without catheter infection. The CDC/NHSN introduced mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) criteria in 2013 to distinguish translocation-associated bacteremia from catheter-attributable infection in surveillance populations. Relevant MBI-LCBI criteria include eligible enteric organisms or viridans streptococci with either absolute neutrophil count (ANC) <500 cells/mm3 on at least 2 separate calendar days in the specified 7-day window, or allogeneic HSCT with grade III-IV gastrointestinal graft-versus-host disease or diarrhea.[6][5]
Endocarditis or other endovascular/metastatic infection Persistent or recurrent bacteremia despite appropriate therapy or catheter removal suggests an occult source that may reseed the bloodstream or catheter. Reassess for infective endocarditis, suppurative thrombophlebitis, osteomyelitis, deep abscess, and other metastatic foci when bacteremia persists after apparent catheter source control.[8]
Non-catheter infectious source Fever or sepsis may arise from pneumonia, urinary infection, surgical/wound infection, skin or soft-tissue infection, sinusitis, CNS infection, or another infectious focus. Do not anchor on the presence of a catheter. The diagnostic evaluation should identify the most plausible primary focus and assess the catheter as one potential source.[9]
Noninfectious fever Drug fever, thromboembolism, postoperative inflammation, and other noninfectious causes may mimic catheter infection, particularly in critically ill patients. Consider noninfectious causes when microbiologic evaluation and examination do not identify an infectious source or when the clinical course is inconsistent with infection.[9]

Distinguishing CRBSI from CLABSI

Central line-associated bloodstream infection (CLABSI) is a surveillance construct and does not establish that the catheter caused the bloodstream infection. CLABSI can therefore include bloodstream infections arising from secondary sources. CRBSI requires clinical and microbiologic attribution of the bloodstream infection to the catheter.[10]

Microbiologic clues to catheter attribution

When CRBSI is suspected, paired blood cultures should generally be obtained before antimicrobial therapy when clinically feasible, with a peripheral culture and cultures from the catheter lumens when catheter attribution is being evaluated. When a multilumen catheter is present, sampling all lumens is useful because colonization may be confined to a single lumen. The 2023 SCCM/IDSA guideline emphasizes peripheral venipuncture because cultures obtained through vascular catheters have greater contamination concerns.[11][12]

Differential time to positivity (DTP): growth from a catheter-drawn blood culture at least 2 hours before growth from a simultaneously obtained peripheral culture, with the same organism recovered, supports the catheter as the source.[13]

A 2023 systematic review and meta-analysis found that DTP ≥2 hours had an overall summary sensitivity of approximately 81%, specificity of approximately 92%, positive likelihood ratio of approximately 9.9, and negative likelihood ratio of approximately 0.20.[14] In routine clinical practice, DTP accuracy has been lower than pooled estimates suggest (reported sensitivity 41-50% and specificity 72-74% in ICU and retrospective cohorts), and it should not be used to rule out CRBSI; catheter culture obtained before antimicrobial therapy remains the most reliable confirmatory method.[15][16] DTP interpretation is further limited when blood cultures are drawn during active antimicrobial therapy (breakthrough bacteremia), which attenuates differential growth and reduces reliability.[16][17]

Quantitative catheter-to-peripheral culture ratios of the same organism, simultaneously drawn, of approximately 3:1 to 10:1 are considered indicative of CRBSI; the exact threshold varies by diagnostic framework.[12]

When the catheter is removed, a semiquantitative (roll-plate) catheter-tip culture ≥15 CFU or a quantitative culture ≥103 CFU/mL, concordant with a positive blood culture, supports catheter attribution; tip culture in the absence of positive blood cultures indicates colonization only.[2][1]

DTP and quantitative attribution methods have important organism-specific limitations: DTP has low sensitivity for Staphylococcus aureus and low specificity for Candida, and performs poorly for coagulase-negative staphylococci, enterococci, and non-AmpC Enterobacterales. A negative attribution test should not by itself exclude CRBSI for these organisms.[14][18] By contrast, DTP discriminates well for AmpC-producing Enterobacterales (AUC 0.94) and moderately for Pseudomonas aeruginosa (AUC 0.84); a DTP cut-off of ≥1 hour may improve sensitivity for AmpC-producing Enterobacterales such as Enterobacter spp.[18]

Organism-specific interpretation

The identity of the organism changes the pretest probability of true bacteremia but does not by itself establish catheter causation. Coagulase-negative staphylococci are common catheter pathogens and also common blood-culture contaminants; corroborating cultures and clinical context are therefore particularly important.[6][5]

Isolation of organisms such as Staphylococcus aureus, Pseudomonas, enterococci, enteric Gram-negative organisms, or Candida should prompt careful assessment for genuine bloodstream infection and potential catheter or metastatic sources. Organism identity should be integrated with the number and timing of positive cultures, clinical findings, and the search for alternative foci.[12][1]

High-yield diagnostic pitfalls

  • Do not equate CLABSI with CRBSI. A surveillance-defined CLABSI does not establish catheter causation.[10]
  • Do not anchor on the catheter. Search for pneumonia, intra-abdominal, urinary, wound, skin/soft-tissue, CNS, and other infectious sources before attributing the BSI to the line.[1][7]
  • Do not diagnose CRBSI from a positive catheter-tip or hub culture alone. With negative blood cultures, a catheter-tip or segment culture ≥15 CFU (semiquantitative) or ≥103 CFU/mL (quantitative) supports colonization rather than bloodstream infection.[1][2]
  • Do not automatically interpret a single positive culture for a common skin commensal as true bacteremia. Seek corroborating cultures and assess the clinical context.[6][5]
  • Do not rely on catheter-drawn cultures alone. Peripheral blood cultures are important both for diagnosing true bacteremia and for source attribution.[11]
  • Do not exclude CRBSI solely because DTP is negative. DTP performance varies by organism and is particularly limited for several clinically important pathogens.[14][18]
  • In neutropenic or mucositis patients, consider mucosal-barrier injury/translocation before attributing bacteremia caused by eligible enteric organisms or viridans streptococci to the catheter.[6][5]
  • Persistent bacteremia after catheter removal requires a search for another source, including endocarditis, suppurative thrombophlebitis, and metastatic infection.[8]

Practical diagnostic approach

  1. Confirm that the patient has a true bloodstream infection rather than contamination or localized catheter colonization.
  2. Obtain appropriately collected paired blood cultures when feasible, including a peripheral specimen and catheter-lumen specimens when catheter attribution is being assessed; sample all lumens of a multilumen catheter when possible.[11][12]
  3. Examine the catheter exit site, tunnel, and port pocket for localized infection.
  4. Search systematically for alternative primary sources of bacteremia or fever.
  5. Assess whether the microbiology supports catheter attribution using concordant organism recovery, DTP, quantitative culture results, or catheter-tip culture when the catheter is removed.[13][2]
  6. In patients with neutropenia or mucositis, consider mucosal-barrier-injury/translocation-associated bacteremia.[6]
  7. If bacteremia persists despite appropriate treatment and catheter removal, reassess for endocarditis, septic thrombophlebitis, deep abscess, osteomyelitis, or another metastatic focus.[8]


References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Miller JM, Binnicker MJ, Campbell S; et al. (2024). "Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)". Clinical Infectious Diseases. doi:10.1093/cid/ciae104.
  2. ↑ 2.0 2.1 2.2 2.3 McGee DC, Gould MK. (2003). "Preventing Complications of Central Venous Catheterization". The New England Journal of Medicine. 348 (12): 1123–1133. doi:10.1056/NEJMra011883.
  3. ↑ Lok CE, Huber TS, Lee T; et al. (2020). "KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update". American Journal of Kidney Diseases. 75 (4 Suppl 2): S1–S164. doi:10.1053/j.ajkd.2019.12.001.
  4. ↑ Zakhour R, Chaftari AM, Raad II. (2016). "Catheter-Related Infections in Patients With Haematological Malignancies: Novel Preventive and Therapeutic Strategies". The Lancet Infectious Diseases. 16 (11): e241–e250. doi:10.1016/S1473-3099(16)30213-4. PMID 27788992.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 Dandoy CE, Alonso PB. (2019). "MBI-LCBI and CLABSI: more than scrubbing the line". Bone Marrow Transplantation. 54 (12): 1932–1939. doi:10.1038/s41409-019-0489-1.
  6. ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Centers for Disease Control and Prevention (2026). "2026 National Healthcare Safety Network (NHSN) Patient Safety Component Manual" (PDF).
  7. ↑ 7.0 7.1 Li J, Zheng Y, Ma J; et al. (2025). "The relationship between catheter-related bloodstream infection and multi-drug resistant bacteria: a five-year retrospective study". BMC Infectious Diseases. 25 (1): 988. doi:10.1186/s12879-025-11367-7.
  8. ↑ 8.0 8.1 8.2 Hastings CA, Torkildson JC, Agrawal AK. (2021). Central Venous Catheters. doi:10.1002/9781119210771.ch26.
  9. ↑ 9.0 9.1 Niven DJ, Laupland KB. (2016). "Pyrexia: aetiology in the ICU". Critical Care. 20: 247. doi:10.1186/s13054-016-1406-2.
  10. ↑ 10.0 10.1 O'Grady NP. (2023). "Prevention of Central Line-Associated Bloodstream Infections". The New England Journal of Medicine. 389 (12): 1121–1131. doi:10.1056/NEJMra2213296.
  11. ↑ 11.0 11.1 11.2 O'Grady NP, Alexander E, Alhazzani W; et al. (2023). "Society of Critical Care Medicine and the Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU". Critical Care Medicine. 51 (11): 1570–1586. doi:10.1097/CCM.0000000000006022.
  12. ↑ 12.0 12.1 12.2 12.3 Böll B, Schalk E, Buchheidt D; et al. (2021). "Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)". Annals of Hematology. 100 (1): 239–259. doi:10.1007/s00277-020-04286-x.
  13. ↑ 13.0 13.1 Raad I, Hanna H, Maki D. (2007). "Intravascular Catheter-Related Infections: Advances in Diagnosis, Prevention, and Management". The Lancet Infectious Diseases. 7 (10): 645–657. doi:10.1016/S1473-3099(07)70235-9. PMID 17897607.
  14. ↑ 14.0 14.1 14.2 Dhaliwal M, Daneman N. (2023). "Utility of Differential Time to Positivity in Diagnosing Central Line-Associated Bloodstream Infections: A Systematic Review and Meta-Analysis". Clinical Infectious Diseases. 77 (3): 428–437. doi:10.1093/cid/ciad225. PMID 37062596 Check |pmid= value (help).
  15. ↑ Bisanti A, Giammatteo V, Bello G; et al. (2023). "Usefulness of Differential Time to Positivity Between Catheter and Peripheral Blood Cultures for Diagnosing Catheter-Related Bloodstream Infection: Data Analysis From Routine Clinical Practice in the Intensive Care Unit". Journal of Critical Care. 75: 154259. doi:10.1016/j.jcrc.2023.154259. PMID 36706553 Check |pmid= value (help).
  16. ↑ 16.0 16.1 Irigoyen-von-Sierakowski Á, Díaz-Navarro M, Visedo A; et al. (2025). "Reliability of Differential Time to Positivity Technique for Diagnosing Catheter-Related Bloodstream Infections: A Retrospective Analysis". Microbiology Spectrum. 13 (6): e0267824. doi:10.1128/spectrum.02678-24. PMID 40197990 Check |pmid= value (help).
  17. ↑ Marco DN, Brey M, Anguera S; et al. (2025). "Time to positivity as a predictor of catheter-related bacteremia and mortality in adults with Pseudomonas aeruginosa bloodstream infection". Critical Care. 29 (1): 63. doi:10.1186/s13054-025-05292-z.
  18. ↑ 18.0 18.1 18.2 Orihuela-Martín J, Rodríguez-Núñez O, Morata L; et al. (2020). "Performance of Differential Time to Positivity as a Routine Diagnostic Test for Catheter-Related Bloodstream Infections: A Single-Centre Experience". Clinical Microbiology and Infection. 26 (3): 383.e1–383.e7. doi:10.1016/j.cmi.2019.07.001. PMID 31288101.
Retrieved from "https://www.wikidoc.org/index.php?title=Catheter-related_bloodstream_infection_differential_diagnosis&oldid=1746406"